Cargando…
Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large‐scale multinational trials (PROFILE 1005 and 1007)
Decreases in heart rate (HR) have been described in patients receiving crizotinib. We performed a large retrospective analysis of HR changes during crizotinib therapy. HRs from vital‐sign data for patients with anaplastic lymphoma kinase (ALK)‐positive nonsmall cell lung cancer enrolled in PROFILE 1...
Autores principales: | Ou, Sai‐Hong Ignatius, Tang, Yiyun, Polli, Anna, Wilner, Keith D., Schnell, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831279/ https://www.ncbi.nlm.nih.gov/pubmed/26823131 http://dx.doi.org/10.1002/cam4.622 |
Ejemplares similares
-
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer
por: Blackhall, Fiona, et al.
Publicado: (2017) -
Complex renal cysts associated with crizotinib treatment
por: Schnell, Patrick, et al.
Publicado: (2015) -
ALK-rearranged lung adenocarcinoma patient with development of severe sinus bradycardia after treatment with crizotinib: A case report
por: Qiu, Ye, et al.
Publicado: (2019) -
Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017) -
Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
por: Selaru, P, et al.
Publicado: (2016)